zurück

EU-HTA

#

What to consider with a PICO proposal?

26.06.2025
PICO Proposal: A Key Advancement in PICO Scoping...
#

EU HTA: Impact to the Industry

24.06.2025
Preparing for Effective EU HTA Implementation: A Multi-Level Approach...
#

From Awareness to Action: Next Steps for EU HTA

17.06.2025
EU HTA Implementation: Progress & Perspectives...
#

EU HTA: State of Implementation

10.06.2025
EU HTA is to support local access. Hence implementation of EU HTA in the member states is essential....
#

Denmark joined our free quarterly newsletter for all the latest updates on HTA

13.05.2025
Get access to our latest update on HTA in Germany by Ecker + Ecker, Canada by MORSE Consulting Inc. and - just joined - Denmark by Zealth ...
#

Canada joined our free quarterly newsletter for all the latest updates on HTA

09.05.2025
Get access to our latest update on HTA in Germany by Ecker+Ecker and Canada by MORSE Consulting Inc. ...
#

Access Briefing: Germany Q4/24

11.04.2025
Get our latest update on HTA in Germany (AMNOG): ....
#

Lichtenstein, Norway and Iceland join the EU HTA family

03.04.2025
EU HTA Expands to 30 Countries! ...
#

New PICO Exercises Released: What Can We Learn?

01.04.2025
Evoque & PICO: Is One Enough? ...
#

New PICO Exercises Released: What Can We Learn?

19.03.2025
Why has publication taken that long? ...
#

New PICO Exercises Released: What Can We Learn?

14.03.2025
PICO Exercise for Accelerated Assessment!...
#

Key Updates on AMNOG & EU HTA Alignment

13.03.2025
Thrilling news ahead: the previously proposed 3-month suspension of the AMNOG process is not included in the final version of the First Regulation Amending the Ordinance on the Benefit Assessment of Medicinal Products...

 

Ansprechpartner

Dr. Thomas Ecker

Dr. Thomas Ecker
Tel. +49 (40) 41 33 081-10

 

Janine Leismann

Janine Leismann
Tel. +49 (40) 41 33 081-26